Akebia Therapeutics, Inc. (AKBA)
1.01
-0.05
(-4.72%)
USD |
NASDAQ |
May 18, 16:00
1.01
0.00 (0.00%)
After-Hours: 16:25
Akebia Therapeutics Market Cap : 270.94M for May 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 11.98B |
| MannKind Corp. | 920.67M |
| United Therapeutics Corp. | 24.08B |
| Ardelyx, Inc. | 1.508B |
| Rhythm Pharmaceuticals, Inc. | 5.952B |
Market Cap Related Metrics
| PS Ratio | 1.171 |
| Price to Book Value | 9.898 |
| Price to Free Cash Flow | 4.533 |
| Price | 1.01 |
| Earnings Yield | -7.63% |
| Operating PE Ratio | 51.46 |